(Q39530479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

bilirubin metabolic disorder

29 January 2020

main subject

Italy

0 references

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Adriano Lazzarin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

C Torti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Lapadula

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Antinori

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

T Quirino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

R Maserati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

F Castelnuovo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

F Maggiolo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Paraninfo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

F Antonucci

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Migliorino

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Di Perri

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Rizzardini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

R Esposito

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Carosi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

26 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

244-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471856%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s15010-008-8010-6

29 January 2020

exact match

0 references

cites work

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS15010-008-8010-6

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS15010-008-8010-6

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS15010-008-8010-6

Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results

21 January 2018

1 reference

12 December 2020

Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results

1 reference

12 December 2020

Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia

1 reference

12 December 2020

Atazanavir plasma concentrations vary significantly between patients and correlate with increased serum bilirubin concentrations

1 reference

12 December 2020

Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.

1 reference

12 December 2020

Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients

1 reference

12 December 2020

Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.

1 reference

12 December 2020

Atazanavir: new option for treatment of HIV infection

1 reference

12 December 2020

Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir

1 reference

12 December 2020